Evidence map›Paper›PMID 31256208›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2019

Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11.

Kinza Younas, Marcos Quintela, Samantha Thomas, Jetzabel Garcia-Parra, Lauren Blake, Helen Whiteland, Adnan Bunkheila, Lewis W Francis, Lavinia Margarit, Deyarina Gonzalez and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Androgens in endometrial carcinoma: the killer or helper?Journal of endocrinological investigation · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kinza YounasReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Marcos QuintelaReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Samantha ThomasReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Jetzabel Garcia-ParraReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Lauren BlakeReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Helen WhitelandReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Adnan BunkheilaReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Lewis W FrancisReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Lavinia MargaritReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
Deyarina GonzalezReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK.
R Steven ConlanReproductive Biology and Gynaecological Oncology, Swansea University Medical School, Singleton Park, Swansea, SA2 8PP, UK. r.s.conlan@swansea.ac.uk.ORCID 0000-0002-2562-3461
Swansea University · GBSwansea Bay University Health Board · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a common gynaecological disorder, with a prevalence of up to 12% of women of reproductive age, and is in part characterised by elevated circulating androgens and aberrant expression of androgen receptor (AR) in the endometrium. A high percentage of PCOS patients suffer from infertility, a condition that appears to be linked to mistimed and incomplete decidualisation critically affecting events surrounding embryo implantation. The aim of this study was to examine the involvement of MAGEA11, and the genome-wide role of AR in PCOS. We determined that elevated androgen levels on PCOS cells had an impact on the delayed and incomplete decidual transformation of endometrial cells. The AR co-regulator MAGEA11, a known enhancer of AR function, was constitutively overexpressed throughout the menstrual cycle of PCOS patients, co-localised in the nucleus of PCOS stromal tissue and cells and formed a molecular complex with AR. Genome-wide AR analysis in PCOS stromal cells revealed that AR targets included genes involved in cell death and apoptosis, as well as genes commonly dysregulated in endometrial cancer. Enhanced MAGEA11 and AR-mediated transcriptional regulation may impact on a correct endometrial decidualisation response, subsequently affecting endometrial receptivity in these infertile women. KEY MESSAGES: MAGEA11 and AR are overexpressed in hyperandrogenic PCOS patients. MAGEA11-AR overexpression in PCOS correlates with delayed decidualisation. AR and MAGEA11 associate in a molecular complex. AR directly regulates a unique set of genes controlling gene differentiation.

Indexed as

AdultAndrogensAntigens, NeoplasmApoptosisCell DeathDeciduaEmbryo ImplantationEndometrial NeoplasmsEndometriumFemaleGene Expression RegulationHumansInfertility, FemaleNeoplasm ProteinsPolycystic Ovary SyndromeReceptors, AndrogenAndrogensAntigens, NeoplasmAR protein, humanMAGEA11 protein, humanNeoplasm ProteinsReceptors, AndrogenARDecidualisationDelayMAGEA11PCOS

Identifiers

PMID31256208
PMCPMC6713698
OpenAlexW2953834653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.